Senior insider sale
Chief Legal Officer at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$78.1K
8.27K shares
What this filing means
BIZILY SCOTT plans to sell 8.27K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $78.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/24/2025ACC: 0001950047-25-008163
Officer· Chief Legal Officer
Since Mar 2022
8.27K
Shares to sell
$78.1K
Approx. market value
1.82K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
10/24/2025
222.00Employee Stock Purchase Plan
Cash
5/14/2024
1.59KTotal acquired1.82K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/24/2025 | Exercise of Stock Options Cash | 222.00 | — |
5/14/2024 | Employee Stock Purchase Plan Cash | 1.59K | — |
| Total | 1.82K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.64K
Market value
$16.6K
10/16/2025
—Completed
Units to sell
2.41K
Market value
$24.1K
10/9/2025
—Completed
Units to sell
2.41K
Market value
$19.3K
9/23/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.82K
Market value
$18.2K
10/24/2025
Total
Units
8.27K
Value
$78.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/16/2025 | 1.64K | $16.6K | — | Completed |
10/9/2025 | 2.41K | $24.1K | — | Completed |
9/23/2025 | 2.41K | $19.3K | — | Completed |
| Planned — Approximate Date | ||||
10/24/2025 | 1.82K | $18.2K | NASDAQ | Planned |
| Total | 8.27K | $78.1K | ||